{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:48:19Z","timestamp":1790898499692,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.autrev.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T21:58:15Z","timestamp":1515794295000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Diagnosis and management of neuromyelitis optica spectrum disorders - An update"],"prefix":"10.1016","volume":"17","author":[{"given":"Alice","family":"Bruscolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"La Cava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Gharbiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Ralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lambiase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"De Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.01.001_bb0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2018.01.001_bb0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/bpa.12087","article-title":"Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status","volume":"23","author":"Sato","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WCO.0000000000000455","article-title":"Neuromyelitis optica and neuromyelitis optica spectrum disorders","volume":"30","author":"Marignier","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2006.02.008","article-title":"Neuromyelitis optica - Devic's syndrome, update","volume":"5","author":"Mandler","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.001_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1756285617709723","article-title":"Differential diagnosis of neuromyelitis optica spectrum disorders","volume":"10","author":"Kim","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.autrev.2018.01.001_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","article-title":"Overlapping CNS inflammatory diseases: differentiating features of NMO and MS","volume":"86","author":"Jurynczyk","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2018.01.001_bb0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","article-title":"Polyarteritis nodosa: a contemporary overview","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.001_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms17030273","article-title":"The immunology of neuromyelitis optica-current knowledge, clinical implications, controversies and future perspectives","volume":"17","author":"Jasiak-Zatonska","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2018.01.001_bb0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","article-title":"Familial neuromyelitis optica","volume":"75","author":"Matiello","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0065","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2009.04.039","article-title":"Environmental changes and epidemiology of multiple sclerosis in the French West Indies","volume":"286","author":"Cabre","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2018.01.001_bb0075","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","article-title":"The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom","volume":"260","author":"Jacob","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.08.032","article-title":"Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan","volume":"323","author":"Houzen","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2018.01.001_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0074-7742(07)79029-3","article-title":"Neuromyelitis optica: new findings on pathogenesis","volume":"79","author":"Wingerchuk","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0090","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.01.001_bb0095","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.01.001_bb0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2018.01.001_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2018.01.001_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2002.020818","article-title":"Aquaporin water channels\u2013from atomic structure to clinical medicine","volume":"542","author":"Agre","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0135","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.neuroscience.2004.08.049","article-title":"Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport","volume":"129","author":"Amiry-Moghaddam","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.autrev.2018.01.001_bb0140","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","article-title":"Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays","volume":"287","author":"Phuan","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2018.01.001_bb0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.autrev.2009.04.004","article-title":"Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica","volume":"9","author":"Saikali","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.001_bb0150","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.01.001_bb0155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.01.001_bb0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.01.001_bb0165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.autrev.2014.01.034","article-title":"Diagnosis and classification of neuromyelitis optica (Devic's syndrome)","volume":"13","author":"Drori","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.001_bb0175","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/archneurol.2012.300","article-title":"Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature review","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ncl.2012.09.010","article-title":"Neuromyelitis optica: clinical manifestations and neuroimaging features","volume":"31","author":"Sahraian","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2018.01.001_bb0185","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0190","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/01.wnl.0000183151.19351.82","article-title":"Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica","volume":"65","author":"Misu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/WNO.0b013e31821d549b","article-title":"Ocular oscillations in the neuromyelitis optica spectrum","volume":"31","author":"Hage","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/NRL.0000000000000057","article-title":"Neuromyelitis optica and neuromyelitis optica spectrum disorder patients in Turkish cohort: demographic, clinical, and laboratory features","volume":"20","author":"Altintas","year":"2015","journal-title":"Neurologist"},{"key":"10.1016\/j.autrev.2018.01.001_bb0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1352458513506953","article-title":"The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders","volume":"20","author":"Huh","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.01.001_bb0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2018.01.001_bb0215","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0220","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson's disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.001_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0230","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1212\/WNL.0000000000003495","article-title":"Child neurology: neuromyelitis optica spectrum disorders","volume":"88","author":"Bradshaw","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0235","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1352458512445944","article-title":"Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features","volume":"19","author":"Absoud","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.01.001_bb0240","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1212\/WNL.0000000000002824","article-title":"Neuromyelitis optica spectrum disorders in children and adolescents","volume":"87","author":"Tenembaum","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.001_bb0245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/WNO.0b013e318254c62d","article-title":"Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis","volume":"32","author":"Khanna","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0250","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1352458514567216","article-title":"Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography","volume":"21","author":"Bennett","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.01.001_bb0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WNO.0b013e31829c510e","article-title":"Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients","volume":"33","author":"Lange","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0260","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1352458516688352","article-title":"Neuromyelitis optica spectrum disorder diagnostic criteria: sensitivity and specificity are both important","volume":"23","author":"Wingerchuk","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.01.001_bb0265","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.01.001_bb0270","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.01.001_bb0275","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","article-title":"Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they?","volume":"30","author":"Reindl","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2018.01.001_bb0285","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2018.01.001_bb0290","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000134","article-title":"Update on biomarkers in neuromyelitis optica","volume":"2","author":"Melamed","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2018.01.001_bb0295","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.autrev.2014.01.009","article-title":"Diagnosis and classification of autoimmune optic neuropathy","volume":"13","author":"Petzold","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.001_bb0305","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaneurol.2015.0248","article-title":"Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder","volume":"72","author":"Kremer","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1352458515581438","article-title":"Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange","volume":"22","author":"Abboud","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.01.001_bb0315","article-title":"Plasma exchange in severe attacks of neuromyelitis optica","volume":"2012","author":"Bonnan","year":"2012","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.autrev.2018.01.001_bb0320","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.4103\/0972-2327.164818","article-title":"Therapy of NMO spectrum disorders","volume":"18","author":"Biswas","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0325","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamaneurol.2013.5699","article-title":"Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy","volume":"71","author":"Mealy","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2015.02.012","article-title":"Analysis of the treatment of neuromyelitis optica","volume":"351","author":"Torres","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2018.01.001_bb0335","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.intimp.2016.03.016","article-title":"Clinical effects of tocilizumab on cytokines and immunological factors in patients with rheumatoid arthritis","volume":"35","author":"Kasama","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.autrev.2018.01.001_bb0340","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamaneurol.2013.668","article-title":"Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses","volume":"70","author":"Kieseier","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0345","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0350","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jamaneurol.2013.1246","article-title":"Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy","volume":"70","author":"Ayzenberg","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0355","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0360","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.22657","article-title":"Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica","volume":"71","author":"Tradtrantip","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0365","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/aps.2011.27","article-title":"Aquaporin-4: orthogonal array assembly, CNS functions, and role in neuromyelitis optica","volume":"32","author":"Verkman","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.autrev.2018.01.001_bb0370","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2169\/internalmedicine.49.4010","article-title":"Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis","volume":"49","author":"Iwata","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2018.01.001_bb0375","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/1352458512440060","article-title":"Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein","volume":"18","author":"Herges","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.01.001_bb0380","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.01.001_bb0385","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1172\/JCI67554","article-title":"Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica","volume":"123","author":"Zhang","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.01.001_bb0390","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000276","article-title":"Restoring immune tolerance in neuromyelitis optica: part I","volume":"3","author":"Steinman","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2018.01.001_bb0395","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000277","article-title":"Restoring immune tolerance in neuromyelitis optica: part II","volume":"3","author":"Bar-Or","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T13:59:33Z","timestamp":1535119173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721830003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S156899721830003X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of neuromyelitis optica spectrum disorders - An update","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}